NCT07230366 · NOT YET RECRUITING

Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders

This trial is testing an AI-powered electric vehicle that helps people with Parkinson's disease or dementia practice walking over a longer period. Researchers want to see whether it is safe and whether it improves gait. This is a Phase NA trial, meaning it is a clinical validation study focused on safety and early benefit signals, not a proven or approved therapy.

You may qualify if

  • Patients with neurodegenerative diseases (such as Parkinson's disease or dementia).
  • Age between 50-85 years.
  • Capable of walking for at least 10 meters, but may have unsteady gait or history of falls.
  • Able to understand the trial procedures and give informed consent.

You're excluded if

  • Severe cardiopulmonary disease or recent major surgery.
  • Unable to walk or requiring comprehensive physical support.
  • Severe cognitive impairment preventing understanding of the trial procedures or giving informed consent.
  • Visual or auditory impairments severe enough to prevent following trial instructions.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-12-10

View full record on ClinicalTrials.gov

All APOE4 clinical trials